Tag: Ophthalmic diseases

Advance in research on the relationship between mammalian target of rapamycin signaling pathway and ophthalmic diseases

2015, No. 11, Review

Authors: Zhang Guiming,  Liu Hongling,  Fu Shaoying DOI: 10.3760/cma.j.issn.2095-0160.2015.11.018 Published 2015-11-10 Cite as Chin J Exp Ophthalmol, 2015,33(11): 1048-1051. Abstract                              [Download PDF] [Read Full Text] Mammalian target of rapamycin (mTOR) is a highly evolutionary conserved protein kinase and plays a critical role […]

Research progress of miR-204 in the regulation of ophthalmic diseases

2017, No. 08, Review

Authors: Xu Yanying,  Mao Xinbang DOI: 10.3760/cma.j.issn.2095-0160.2017.08.020 Published 2017-08-10 Cite as Chin J Exp Ophthalmol, 2017,35(8): 761-763. Abstract                              [Download PDF] [Read Full Text] MicroRNAs (miRNAs) are endogenous short nucleotide non-coding RNAs which widely exist in eukaryotic organisms, involved in the body’s life process, including cell growth, differentiation, […]

Review on progress of choroidal thickness

2017, No. 10, Review

Authors: He Lyufu,  Wang Xiaohua,  Wen Xu DOI: 10.3760/cma.j.issn.2095-0160.2017.10.021 Published 2017-10-10 Cite as Chin J Exp Ophthalmol, 2017,35(10): 949-954. Abstract                               [Download PDF] [Read Full Text] The introduction of optical coherence tomography (OCT) into clinical practice has changed methods of the ophthalmic clinical diagnosis and treatment.With the progression of […]

Accelerating the construction of artificial intelligence diagnostic platform based on ophthalmic imaging database

2018, No. 08, Editorial

Authors: Lin Haotian,  Wu Xiaohang DOI: 10.3760/cma.j.issn.2095-0160.2018.08.001 Published 2018-08-10 Cite as Chin J Exp Ophthalmol, 2018,36(8): 577-580. Abstract                              [Download PDF] [Read Full Text] With the global trend of aging populations, the prevalence of blindness is expected to increase.However, due to deficiencies and imbalances, […]